Source: Eur Respir J 2004; 23: 391-395
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Suissa S.. Inhaled steroids and mortality in COPD: bias from unaccounted immortal time. Eur Respir J 2004; 23: 391-395

Member's Comments

No comment yet.

Related content which might interest you: Inhaled steroids and mortality in COPD: bias from unaccounted immortal time Source: Eur Respir J 2004; 24: 190-191 Year: 2004 Methodological issues in therapeutic trials of COPD Source: Eur Respir J 2008; 31: 927-933 Year: 2008 Bias in retrospective studies of trends in asthma incidence Source: Eur Respir J 2004; 23: 281-286 Year: 2004 Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Source: Eur Respir J 2002; 19: 1179-1193 Year: 2002 Avoiding immortal time bias in observational studies Source: Eur Respir J, 55 (3) 2000138; 10.1183/13993003.00138-2020 Year: 2020 Avoiding immortal time bias in observational studies Source: Eur Respir J, 55 (3) 1902494; 10.1183/13993003.02494-2019 Year: 2020 Female gender, uncontrolled asthma, and confounding bias in a ‘real life’ population study. Source: International Congress 2019 – Asthma and the world Year: 2019 Evaluating the effects of asthma therapy on childhood growth: principles of study design Source: Eur Respir J 2002; 19: 1167-1178 Year: 2002 Does adherence to inhaled corticosteroids predict asthma-related outcomes over time? A cohort study Source: Eur Respir J, 54 (6) 1900901; 10.1183/13993003.00901-2019 Year: 2019 Patterns of risk of death and asthma-related adverse outcomes in adult asthma patients receiving long-acting β2-agonist (LABA) therapy: results from the UK general practice research database (GPRD) Source: Annual Congress 2009 - Asthma treatment and control strategies in primary care Year: 2009 The long-term clinical and economic impact of COPD exacerbations: an observational study (SHERLOCK) Source: Virtual Congress 2020 – Prediction and management of outcomes in obstructive diseases Year: 2020 Recent trends in inhaled corticosteroid prescriptions and its impact on COPD management: an analysis of the KOLD/KOCOSS cohorts Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019 COVID-19 risk and outcomes in adult asthmatics treated with biologics or systemic corticosteroids: nationwide real-world evidence. Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Different definitions in childhood asthma: how dependable is the dependent variable? Source: Eur Respir J 2010; 36: 48-56 Year: 2010 What predicts poor collection of medication among children with asthma? A case-control study Source: Eur Respir J 2002; 20: 1464-1469 Year: 2002 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Changes in the use of anti-asthmatic medication in an international cohort Source: Eur Respir J 2005; 26: 1047-1055 Year: 2005 Does the use of inhaled corticosteroids in asthma benefit lung function in the long-term? A systematic review and meta-analysis Source: Eur Respir Rev, 30 (159) 200185; 10.1183/16000617.0185-2020 Year: 2021 Long-acting bronchodilator initiation in COPD and cardio-pulmonary risks: A population-based comparative effectiveness study Source: International Congress 2016 – Novel avenues in the treatment of COPD II Year: 2016